Keyphrases
Polycystic Ovary Syndrome
100%
Systematic Meta-analysis
67%
Meta-analysis
67%
Assisted Reproductive Technology
60%
Postpartum Contraception
45%
Hyperprolactinemia
45%
Confidence Interval
42%
Pregnancy Rate
41%
Prolactin
33%
Insulin
32%
Insulin Resistance
31%
Hirsutism
30%
Randomized Trial
30%
Insulin Sensitizers
30%
Follicular Phase
28%
Unprotected Sex
27%
Fertility Treatment
26%
Live Birth Rate
26%
Overweight or Obesity
26%
Infertile Women
25%
Gestational Diabetes
25%
Hyperinsulinism
24%
Levonorgestrel
24%
Ethinylestradiol
24%
Metoclopramide
22%
Macroprolactinemia
22%
Follicular Phase Stimulation
22%
Weight Decrease
22%
Self-scoring
22%
Letrozole
22%
Female Fertility Preservation
22%
Gonadotropin-releasing Hormone Antagonist
22%
Random Start
22%
Pelvic Floor muscle Training
22%
Metabolic Syndrome
22%
Serum Androgens
22%
Obese Women
22%
Weight Loss
22%
Physical Activity Intervention
22%
Individual Participant Data Meta-analysis
22%
Lifestyle Intervention
22%
Birth Outcomes
22%
Observational Comparative Studies
22%
Intervention Group
22%
Effectiveness Evaluation
22%
Treatment Protocol
22%
Response Profiles
22%
Pregnancy Outcome
22%
Human Chorionic Gonadotropin
22%
Pituitary Response
22%
Medicine and Dentistry
Meta-Analysis
90%
Systematic Review
90%
Polycystic Ovary Syndrome
70%
Assisted Reproduction
48%
Pregnancy Rate
43%
Assisted Reproductive Technology
35%
Androgen
33%
Insulin Resistance
33%
Hirsutism
30%
Follicular Phase
28%
Hyperinsulinism
27%
Insulin Sensitizing Agent
26%
Clinician
26%
Obesity
26%
Birth Rate
26%
Gestational Diabetes
25%
Emergency Contraception
22%
Prevalence
22%
Gonadorelin Antagonist
22%
Physical Activity
22%
Fertility Preservation
22%
Body Weight Loss
22%
Chorionic Gonadotropin
22%
Glucose Metabolism
22%
Urine Incontinence
22%
Kegel Exercise
22%
Letrozole
22%
Levonorgestrel
22%
Microscopy
22%
Unwanted Pregnancy
22%
Vagina Smear
22%
Ethinylestradiol
22%
Randomized Controlled Trial
22%
Birth Outcomes
22%
Lifestyle Intervention
22%
Enuresis
22%
Oocyte
20%
Spontaneous Abortion
18%
Follitropin
17%
Reproductive Medicine
15%
Menstrual Cycle
13%
Glycon
13%
Quantitative Insulin Sensitivity Check Index
12%
Diethylstilbestrol
11%
Controlled Ovarian Hyperstimulation
11%
Randomized Clinical Trial
9%
Impaired Glucose Tolerance
8%
Testosterone
8%
Glucose Tolerance
8%
Hyperandrogenism
7%